Literature DB >> 11970879

IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity.

Marion T Kasaian1, Matthew J Whitters, Laura L Carter, Leslie D Lowe, Jason M Jussif, Bijia Deng, Kaley A Johnson, JoAnn S Witek, Mayra Senices, Richard F Konz, Andrea L Wurster, Debra D Donaldson, Mary Collins, Deborah A Young, Michael J Grusby.   

Abstract

IFNalpha/beta, IL-12, and IL-15 regulate NK cell activation and expansion, but signals triggering resolution of the NK response upon induction of adaptive immunity remain to be defined. We now report that IL-21, a product of activated T cells, may serve this function. Mice lacking IL-21R (IL-21R(-/-)) had normal NK cell development but no detectable responses to IL-21. IL-21 enhanced cytotoxic activity and IFNgamma production by activated murine NK cells but did not support their viability, thus limiting their duration of activation. Furthermore, IL-21 blocked IL-15-induced expansion of resting NK cells, thus preventing the initiation of further innate responses. In contrast, IL-21 enhanced the proliferation, IFNgamma production, and cytotoxic function of CD8(+) effector T cells in an allogeneic MLR. These observations suggest that IL-21 promotes the transition between innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11970879     DOI: 10.1016/s1074-7613(02)00295-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  136 in total

1.  IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms.

Authors:  Vinh Nguyen; Irina Luzina; Horea Rus; Cosmin Tegla; Ching Chen; Violeta Rus
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

2.  IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells.

Authors:  Elizabeth L McMichael; Alena Cristina Jaime-Ramirez; Kristan D Guenterberg; Eric Luedke; Lakhvir S Atwal; Amanda R Campbell; Zhiwei Hu; Armika S Tatum; Sri Vidya Kondadasula; Xiaokui Mo; Susheela Tridandapani; Mark Bloomston; E Christopher Ellison; Terence M Williams; Tanios Bekaii-Saab; William E Carson
Journal:  Clin Cancer Res       Date:  2016-07-19       Impact factor: 12.531

3.  Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor.

Authors:  Elizabeth L McMichael; Nicholas B Courtney; Megan C Duggan; Robert Wesolowski; Dionisia Quiroga; Sri Vidya Kondadasula; Lakhvir S Atwal; Neela Bhave; Eric Luedke; Alena Cristina Jaime-Ramirez; Amanda R Campbell; Xiaokui Mo; John C Byrd; William E Carson Iii
Journal:  Oncoimmunology       Date:  2017-05-02       Impact factor: 8.110

4.  Characterization of ectopic lymphoid structures in different types of acute renal allograft rejection.

Authors:  K de Leur; M C Clahsen-van Groningen; T P P van den Bosch; G N de Graav; D A Hesselink; J N Samsom; C C Baan; K Boer
Journal:  Clin Exp Immunol       Date:  2018-02-02       Impact factor: 4.330

5.  IL-21 is required for CD4 memory formation in response to viral infection.

Authors:  Yuqing Yuan; Yiping Yang; Xiaopei Huang
Journal:  JCI Insight       Date:  2017-04-06

6.  IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes.

Authors:  Michal Marzec; Xiaobin Liu; Monika Kasprzycka; Agnieszka Witkiewicz; Puthiyaveettil N Raghunath; Mouna El-Salem; Erle Robertson; Niels Odum; Mariusz A Wasik
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

7.  IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice.

Authors:  Haoli Jin; Michiko K Oyoshi; Yi Le; Teresa Bianchi; Suresh Koduru; Clinton B Mathias; Lalit Kumar; Séverine Le Bras; Deborah Young; Mary Collins; Michael J Grusby; Joerg Wenzel; Thomas Bieber; Marianne Boes; Leslie E Silberstein; Hans C Oettgen; Raif S Geha
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

8.  IL-21 receptor signalling partially mediates Th2-mediated allergic airway responses.

Authors:  S Lajoie; I Lewkowich; N S Herman; A Sproles; J T Pesce; T A Wynn; M J Grusby; Q Hamid; M Wills-Karp
Journal:  Clin Exp Allergy       Date:  2014-07       Impact factor: 5.018

9.  IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma.

Authors:  Jennifer Dien Bard; Pascal Gelebart; Mona Anand; Zoulika Zak; Samar A Hegazy; Hesham M Amin; Raymond Lai
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

10.  Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21.

Authors:  Sascha Ansén; Marcus O Butler; Alla Berezovskaya; Andrew P Murray; Kristen Stevenson; Lee M Nadler; Naoto Hirano
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.